Skip to content

Assessment of Quality of life in Chronic lung disease

Evaluation of Structured Individualized Pharmacist Intervention Programme On Economic, Clinical, and Humanistic Outcomes of COPD Patients In A Tertiary Care Hospital

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/08/004848
Enrollment
260
Registered
2014-08-08
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Chronic Obstructive Pulmonary Disorder (COPD)patients

Interventions

Intervention1: Pharmacists Intervention to COPD patients: Patient will be counseled by using various suitable education materials like patient information leaflets for once in every six months for tw

Sponsors

Suhaj A
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Confirmed diagnosis of COPD patients aged between 40 and 70 of both genders will be included in the study after getting their informed consent.

Exclusion criteria

Exclusion criteria: Clinically unstable, severe mobility problem patients were excluded from the study

Design outcomes

Primary

MeasureTime frame
Health related quality of life,Timepoint: Baseline, 6, 12, 18 & 24 months

Secondary

MeasureTime frame
Medication adherence, COPD knowledge level, estimated treatment cost, FEV1Timepoint: baseline, 6, 12, 18 & 24 months.

Countries

India

Contacts

Public ContactSuhaj A

Manipal College of Pharmaceutical Sciences

a.suhaj@gmail.com0820-2922403

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Mar 14, 2026